Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Journal of Gastrointestinal Surgery
Erschienen in: Journal of Gastrointestinal Surgery 12/2015

01.12.2015 | Original Article

Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery

verfasst von: Samer Tohme, Julie Goswami, Katrina Han, Alexis P. Chidi, David A. Geller, Srinevas Reddy, Ana Gleisner, Allan Tsung

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Previous studies have shown benefit not only from postoperative chemotherapy but also from a short interval to initiation of treatment after resection of primary colorectal cancer. The aim of this study was to determine difference in timing to postoperative chemotherapy for minimally invasive resection (MIR) vs. open resection (OR) of colorectal cancer liver metastases (CRCLM).

Methods

This is a retrospective review of 1:1 matched patients undergoing MIR (n = 66) and OR (n = 66) for CRCLM at a single institution.

Results

Patients undergoing MIR of CRCLM had significantly shorter length of hospital stay, fewer major complications, and shorter interval to postoperative chemotherapy (median 42 vs. 63 days, p < 0.001). Univariable analysis showed that surgical approach, postoperative complications, blood loss, number of lesions, and length of stay were associated with timing to chemotherapy. On multivariable analysis, surgical approach was still associated with timing to chemotherapy, and postoperative complications resulted in a delay of chemotherapy among patients who underwent OR but not among those who underwent MIR. In addition, worse disease-free survival was seen among patients who received postoperative chemotherapy more than 60 days after surgery.

Conclusion

By modifying the deleterious effects of postoperative complications on timing of postoperative chemotherapy, patients undergoing MIR for CRCLM are treated with chemotherapy sooner after surgery compared to those undergoing OR.
Literatur
1.
R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA Cancer J Clin, vol. 65, pp. 5-29, 2015.CrossRefPubMed
2.
S. Manfredi, C. Lepage, C. Hatem, O. Coatmeur, J. Faivre, and A. M. Bouvier, “Epidemiology and management of liver metastases from colorectal cancer,” Ann Surg, vol. 244, pp. 254-9, 2006.PubMedCentralCrossRefPubMed
3.
E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J. N. Vauthey, and D. Mahvi, “Improving resectability of hepatic colorectal metastases: expert consensus statement,” Ann Surg Oncol, vol. 13, pp. 1271-80, 2006.CrossRefPubMed
4.
T. A. Aloia, J. N. Vauthey, E. M. Loyer, D. Ribero, T. M. Pawlik, S. H. Wei, et al., “Solitary colorectal liver metastasis: resection determines outcome,” Arch Surg, vol. 141, pp. 460-6; discussion 466-7, 2006.CrossRefPubMed
5.
M. A. Choti, J. V. Sitzmann, M. F. Tiburi, W. Sumetchotimetha, R. Rangsin, R. D. Schulick, et al., “Trends in long-term survival following liver resection for hepatic colorectal metastases,” Ann Surg, vol. 235, pp. 759-66, 2002.PubMedCentralCrossRefPubMed
6.
S. Kopetz, G. J. Chang, M. J. Overman, C. Eng, D. J. Sargent, D. W. Larson, et al., “Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy,” J Clin Oncol, vol. 27, pp. 3677-83, 2009.PubMedCentralCrossRefPubMed
7.
R. M. Goldberg, D. J. Sargent, R. F. Morton, C. S. Fuchs, R. K. Ramanathan, S. K. Williamson, et al., “Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial,” J Clin Oncol, vol. 24, pp. 3347-53, 2006.CrossRefPubMed
8.
K. T. Nguyen, T. C. Gamblin, and D. A. Geller, “World review of laparoscopic liver resection-2,804 patients,” Ann Surg, vol. 250, pp. 831-41, 2009.CrossRefPubMed
9.
K. T. Nguyen and D. A. Geller, “Outcomes of laparoscopic hepatic resection for colorectal cancer metastases,” J Surg Oncol, vol. 102, pp. 975-7, 2010.CrossRefPubMed
10.
K. T. Nguyen, A. Laurent, I. Dagher, D. A. Geller, J. Steel, M. T. Thomas, et al., “Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes,” Ann Surg, vol. 250, pp. 842-8, 2009.CrossRefPubMed
11.
K. T. Nguyen, J. W. Marsh, A. Tsung, J. J. Steel, T. C. Gamblin, and D. A. Geller, “Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal,” Arch Surg, vol. 146, pp. 348-56, 2011.CrossRefPubMed
12.
D. Castaing, E. Vibert, L. Ricca, D. Azoulay, R. Adam, and B. Gayet, “Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centers,” Ann Surg, vol. 250, pp. 849-55, 2009.CrossRefPubMed
13.
A. M. Kazaryan, I. P. Marangos, B. I. Rosok, A. R. Rosseland, O. Villanger, E. Fosse, et al., “Laparoscopic resection of colorectal liver metastases: surgical and long-term oncologic outcome,” Ann Surg, vol. 252, pp. 1005-12, 2010.CrossRefPubMed
14.
S. C. Schiffman, K. H. Kim, A. Tsung, J. W. Marsh, and D. A. Geller, “Laparoscopic versus open liver resection for metastatic colorectal cancer: A metaanalysis of 610 patients,”Surgery 2015 157(2):211-22CrossRefPubMed
15.
A. Tsung, D. A. Geller, D. C. Sukato, S. Sabbaghian, S. Tohme, J. Steel, et al., “Robotic versus laparoscopic hepatectomy: a matched comparison,” Ann Surg, vol. 259, pp. 549-55, 2014.CrossRefPubMed
16.
E. Berber, H. Y. Akyildiz, F. Aucejo, G. Gunasekaran, S. Chalikonda, and J. Fung, “Robotic versus laparoscopic resection of liver tumours,” HPB (Oxford), vol. 12, pp. 583-6, 2010.CrossRef
17.
E. C. Lai, G. P. Yang, and C. N. Tang, “Robot-assisted laparoscopic liver resection for hepatocellular carcinoma: short-term outcome,” Am J Surg, vol. 205, pp. 697-702, 2013.CrossRefPubMed
18.
G. Portier, D. Elias, O. Bouche, P. Rougier, J. F. Bosset, J. Saric, et al., “Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial,” J Clin Oncol, vol. 24, pp. 4976-82, 2006.CrossRefPubMed
19.
B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, P. M. Schlag, P. Rougier, et al., “Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial,” Lancet, vol. 371, pp. 1007-16, 2008.PubMedCentralCrossRefPubMed
20.
B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, P. M. Schlag, P. Rougier, et al., “Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial,” Lancet Oncol, vol. 14, pp. 1208-15, 2013.CrossRefPubMed
21.
N. Gunduz, B. Fisher, and E. A. Saffer, “Effect of surgical removal on the growth and kinetics of residual tumor,” Cancer Res, vol. 39, pp. 3861-5, 1979.PubMed
22.
B. Fisher, N. Gunduz, J. Coyle, C. Rudock, and E. Saffer, “Presence of a growth-stimulating factor in serum following primary tumor removal in mice,” Cancer Res, vol. 49, pp. 1996-2001, 1989.PubMed
23.
M. Baum, R. Demicheli, W. Hrushesky, and M. Retsky, “Does surgery unfavourably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases?,” Eur J Cancer, vol. 41, pp. 508-15, 2005.CrossRefPubMed
24.
J. J. Biagi, M. J. Raphael, W. J. Mackillop, W. Kong, W. D. King, and C. M. Booth, “Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis,” JAMA, vol. 305, pp. 2335-42, 2011.CrossRefPubMed
25.
S. K. Reddy, J. W. Marsh, P. R. Varley, B. K. Mock, K. B. Chopra, D. A. Geller, et al., “Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study,” Hepatology, vol. 56, pp. 2221-30, 2012CrossRefPubMed
26.
J. Belghiti, K. Hiramatsu, S. Benoist, P. Massault, A. Sauvanet, and O. Farges, “Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection,” J Am Coll Surg, vol. 191, pp. 38-46, 2000.CrossRefPubMed
27.
D. Dindo, N. Demartines, and P. A. Clavien, “Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey,” Ann Surg, vol. 240, pp. 205-13, 2004.PubMedCentralCrossRefPubMed
28.
T. L. Frankel and M. I. D’Angelica, “Hepatic resection for colorectal metastases,” J Surg Oncol, vol. 109, pp. 2-7, 2014.CrossRefPubMed
29.
M. G. House, H. Ito, M. Gonen, Y. Fong, P. J. Allen, R. P. DeMatteo, et al., “Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution,” J Am Coll Surg, vol. 210, pp. 744-52, 752-5, 2010.CrossRefPubMed
30.
B. Nordlinger, M. Guiguet, J. C. Vaillant, P. Balladur, K. Boudjema, P. Bachellier, et al., “Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie,” Cancer, vol. 77, pp. 1254-62, 1996.CrossRefPubMed
31.
J. S. Tomlinson, W. R. Jarnagin, R. P. DeMatteo, Y. Fong, P. Kornprat, M. Gonen, et al., “Actual 10-year survival after resection of colorectal liver metastases defines cure,” J Clin Oncol, vol. 25, pp. 4575-80, 2007.CrossRefPubMed
32.
K. P. Croome, M. B. Farnell, F. G. Que, K. M. Reid-Lombardo, M. J. Truty, D. M. Nagorney, et al., “Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?,” Ann Surg, vol. 260, pp. 633-8; discussion 638-40, 2014.CrossRefPubMed
33.
A. R. Day, G. Middleton, R. V. Smith, I. C. Jourdan, and T. A. Rockall, “Time to adjuvant chemotherapy following colorectal cancer resection is associated with an improved survival,” Colorectal Dis, vol. 16, pp. 368-72, 2014.CrossRefPubMed
34.
J. H. Wang, T. M. King, M. C. Chang, and C. W. Hsu, “Comparison of the feasibility of laparoscopic resection of the primary tumor in patients with stage IV colon cancer with early and advanced disease: the short- and long-term outcomes at a single institution,” Surg Today, vol. 43, pp. 1116-22, 2013.CrossRefPubMed
35.
T. A. Aloia, G. Zimmitti, C. Conrad, V. Gottumukalla, S. Kopetz, and J. N. Vauthey, “Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy,” J Surg Oncol, vol. 110, pp. 107-14, 2014.CrossRefPubMed
Metadaten
Titel
Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery
verfasst von
Samer Tohme
Julie Goswami
Katrina Han
Alexis P. Chidi
David A. Geller
Srinevas Reddy
Ana Gleisner
Allan Tsung
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 12/2015
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2962-5

Weitere Artikel der Ausgabe 12/2015

Journal of Gastrointestinal Surgery 12/2015 Zur Ausgabe

Original Article

Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma

Original Article

Prevention of Postoperative Bile Leak in Partial Cystectomy for Hydatid Liver Disease: Tricks of the Trade

How I do it

The Barcelona Technique for Ileostomy Reversal

Original Article

Acute Appendicitis in the Adult Population: Modelled Decision Analysis Supports a Conservative Approach

How I do it

Cattell-Braasch Maneuver Combined with Artery-First Approach for Superior Mesenteric-Portal Vein Resection During Pancreatectomy

Original Article

Repeat Hepatectomy for Recurrent Colorectal Liver Metastases: Is it Worth the Challenge?

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | HNO-Chirurgie | Nachrichten

HNO-Op. auch mit über 90?

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.